-+ 0.00%
-+ 0.00%
-+ 0.00%

Aardvark Therapeutics appoints Abivax Chief Strategy Officer David Zhang to board

PUBT·10/08/2026 12:01:50
Listen to the news
Aardvark Therapeutics appoints Abivax Chief Strategy Officer David Zhang to board
  • Aardvark Therapeutics appointed David Zhang to its board as an independent director, effective Oct. 7, 2026.
  • Zhang is chief strategy officer at Abivax, overseeing biometrics, regulatory affairs, quality assurance, HEOR.
  • He previously led biometrics and data management at Alumis, served as interim CIO, supported the company through its IPO.
  • Earlier roles include biometrics leadership at MyoKardia on CAMZYOS clinical strategy and NDA work, roles at Genentech/Roche.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aardvark Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080800PRIMZONEFULLFEED9841760) on October 08, 2026, and is solely responsible for the information contained therein.